Lisdexamfetamine Dimesylate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0054-0373
  • Package NDC 0054-0373-25
  • Application number ANDA202827
  • SPL ID ccd9e87c-bd03-4fe0-8129-41c1ced49c8d
  • SPL set ID 6740a621-9bec-4178-a4fc-a3fc89f34e0a
  • UNII SJT761GEGS
  • RxCUI 854830
  • RxCUI 854834
  • RxCUI 854838
  • RxCUI 854842
  • RxCUI 854846
  • RxCUI 854850
  • RxCUI 1593856

What the source publishes

Labeler
Hikma Pharmaceuticals USA Inc.
Active ingredients
lisdexamfetamine dimesylate
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0054-0373_ccd9e87c-bd03-4fe0-8129-41c1ced49c8d
{
  "name": "Lisdexamfetamine Dimesylate",
  "splId": "ccd9e87c-bd03-4fe0-8129-41c1ced49c8d",
  "labels": [
    {
      "setId": "6740a621-9bec-4178-a4fc-a3fc89f34e0a",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6740a621-9bec-4178-a4fc-a3fc89f34e0a",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Hikma Pharmaceuticals USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 CAPSULE in 1 BOTTLE (0054-0373-25)",
      "package_ndc": "0054-0373-25",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230825"
    }
  ],
  "productId": "0054-0373_ccd9e87c-bd03-4fe0-8129-41c1ced49c8d",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "0054-0373",
  "deaSchedule": "CII",
  "genericName": "lisdexamfetamine dimesylate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LISDEXAMFETAMINE DIMESYLATE",
      "strength": "50 mg/1"
    }
  ],
  "applicationNumber": "ANDA202827",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230825",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0300540370251",
      "0300540660253",
      "0300540371258"
    ],
    "unii": [
      "SJT761GEGS"
    ],
    "rxcui": [
      "854830",
      "854834",
      "854838",
      "854842",
      "854846",
      "854850",
      "1593856"
    ],
    "spl_set_id": [
      "6740a621-9bec-4178-a4fc-a3fc89f34e0a"
    ],
    "manufacturer_name": [
      "Hikma Pharmaceuticals USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0054-0373_ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"